Skip to main content
JADPRO Live 2024 Main banner
Icon Legend
ICONS KEY
CE Credit Available
CE Credit Available
Pharmacology Credit Available
Pharmacology Credit Available
Poster Activities
Poster Activities
Surgical Oncology
Surgical Oncology
Back

JADPRO Live 2024

On-Demand: New Drug Updates: Solid Tumors

Wednesday, November 20, 2024
Location: Grapevine Ballroom
CE: 1.00 credits/hours

Disclosures:

Megan May has served on advisory boards for AstraZeneca, Daiichi Sankyo, Genentech, GlaxoSmithKline, and Lilly, on speakers bureaus for Amgen and AstraZeneca, and as a consultant for Lilly.

Learning Objectives:

  • Recall the approved label indications of new drugs and biologics in hematology/oncology
  • Match the names of new and emerging oncology drugs with their mechanisms of action
  • Safely manage treatment-related adverse events in patients receiving newly approved drugs and biologics in hematology/oncology, especially bispecific antibodies